|Printable version||E-mail this to a friend|
BHF - Study says screening could prevent 600 heart attacks in people under 40
Research suggests that screening children for the inherited genetic disorder familial hypercholesterolaemia (FH) could prevent unnecessary deaths.
The research, from Queen Mary University of London (QMUL), found that of more than 10,000 children who were tested for FH genetic mutations and high cholesterol, 40 children were identified to be FH positive.
Once an FH positive child was found, the parents were contacted for screening, which led to an additional parent being diagnosed with FH in each case.
People with FH have higher levels of cholesterol in their blood and are subsequently at higher risk of suffering a potentially deadly heart attack or stroke at a young age. However, with early detection, people with FH can manage the condition with medication and lead a normal life.
From bench to bedside
BHF research led to the development of the test for FH. We have since funded ‘cascade testing centres’ in Wales and England where high risk family members can have a simple blood test to determine if they have the condition. However its rollout across the NHS has been slow.
What BHF think
BHF Medical Director, Professor Sir Nilesh Samani, said:
"The majority of people living with familial hypercholesterolaemia are still undiagnosed, putting them at higher risk of suffering a deadly heart attack or stroke before they reach 50.
“Early diagnosis in children is likely to substantially improve treatment of their condition and will help find other family members with FH. But before nationwide screening is adopted by the NHS more work needs to be done to show it’s a cost-effective way for picking up individuals with FH which will be acceptable to families.
“Current NICE guidance recommends that the most effective screening model is for family members of those diagnosed with FH to be tested, based on BHF-funded research showing the life saving potential and cost effectiveness of running this type of cascade testing programme.
“However, rollout across the NHS has been slow, meaning people are missing out on treatment to lower their risk of an early heart attack or stroke. Before any future change in practice based on this new research, the widespread rollout of the current cascade testing programme is vital if we’re to prevent people unnecessarily dying from FH”.
Following thirty years of research to find the genes responsible for FH, national guidelines were introduced in 2008 recommending family members of FH patients should be offered genetic testing.
Suzanne Sheppard, found out she had FH after her dad died from a heart attack aged just 41. “When I found out I had FH there was a certain sense of relief to know why my cholesterol was so high. Now my son will be screened and if he does have FH it will be identified at a young age and he will receive the same level of care and treatment that I have received."
Find out more about our Genetic Information Service.
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.